Harvard Bioscience Long Term Debt 2012-2026 | HBIO

Harvard Bioscience long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Harvard Bioscience Annual Long Term Debt
(Millions of US $)
2025 $36
2024
2023 $31
2022 $43
2021 $45
2020 $46
2019 $47
2018 $55
2017 $9
2016 $11
2015 $16
2014 $16
2013 $20
2012 $13
2011 $16
Harvard Bioscience Quarterly Long Term Debt
(Millions of US $)
2026-03-31 $36
2025-12-31 $36
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30 $34
2024-06-30 $32
2024-03-31 $32
2023-12-31 $31
2023-09-30 $35
2023-06-30 $38
2023-03-31 $41
2022-12-31 $43
2022-09-30 $47
2022-06-30 $46
2022-03-31 $46
2021-12-31 $45
2021-09-30 $43
2021-06-30 $41
2021-03-31 $42
2020-12-31 $46
2020-09-30 $41
2020-06-30 $41
2020-03-31 $46
2019-12-31 $47
2019-09-30 $52
2019-06-30 $52
2019-03-31 $54
2018-12-31 $55
2018-09-30 $59
2018-06-30 $60
2018-03-31 $62
2017-12-31 $9
2017-09-30 $10
2017-06-30 $10
2017-03-31 $11
2016-12-31 $11
2016-09-30 $13
2016-06-30 $14
2016-03-31 $15
2015-12-31 $16
2015-09-30 $15
2015-06-30 $16
2015-03-31 $17
2014-12-31 $16
2014-09-30 $18
2014-06-30 $17
2014-03-31 $19
2013-12-31 $20
2013-09-30 $21
2013-06-30 $21
2013-03-31 $12
2012-12-31 $13
2012-09-30 $15
2012-06-30 $16
2012-03-31 $17
2011-12-31 $16
2011-09-30 $16
2011-06-30 $17
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.019B $0.087B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.722B 20.54
Kewaunee Scientific (KEQU) United States $0.100B 8.24